Cytogenetic alterations in nonmelanoma skin cancer: A review

Genes Chromosomes and Cancer

Volumn 43, Issue 3, 2005, Pages 239-248

  Ashton, Kevin J ^a   Carless, Melanie A ^a   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ACTINIC KERATOSIS; BASAL CELL CARCINOMA; BOWEN DISEASE; CANCER CLASSIFICATION; CANCER GROWTH; CANCER STAGING; CHROMOSOME ABERRATION; COMPARATIVE GENOMIC HYBRIDIZATION; CYTOGENETICS; FLUORESCENCE IN SITU HYBRIDIZATION; HUMAN; KERATOACANTHOMA; LASER CAPTURE MICRODISSECTION; MELANOMA; METASTASIS POTENTIAL; PRIORITY JOURNAL; REVIEW; SKIN CANCER; SOLID TUMOR; SQUAMOUS CELL CARCINOMA;

CHROMOSOME ABERRATIONS; CHROMOSOME MAPPING; DNA DAMAGE; HUMANS; IN SITU HYBRIDIZATION, FLUORESCENCE; KARYOTYPING; LOSS OF HETEROZYGOSITY; MUTATION; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 19444383099     PISSN: 10452257     EISSN: None     Source Type: Journal    
DOI: 10.1002/gcc.20183     Document Type: Review

References (99)

1. Agar NS, Halliday GM, Barnetson RS, Jones AM. 2003. A novel technique for the examination of skin biopsies by laser capture microdissection. J Cutan Pathol 30:265-270.
2. Agar NS, Halliday GM, Barnetson RS, Ananthaswamy HN, Wheeler M, Jones AM. 2004. The basal layer in human squamous tumors harbors more UVA than UVB fingerprint mutations: a role for UVA in human skin carcinogenesis. Proc Natl Acad Sci USA 101:4954-4959.
3. Albert MR, Weinstock MA. 2003. Keratinocyte carcinoma. CA Cancer J Clin 53:292-302.
4. Aledo R, Aurias A, Chretien B, Dutrillaux B. 1988. Jumping translocation of chromosome 14 in a skin squamous cell carcinoma from a xeroderma pigmentosum patient. Cancer Genet Cytogenet 33:29-33.
5. Almahroos M, Kurban AK. 2004a. Ultraviolet carcinogenesis in non-melanoma skin cancer. Part I: incidence rates in relation to geographic locations and in migrant populations. Skinmed 3:29-35.
6. Almahroos M, Kurban AK. 2004b. Ultraviolet carcinogenesis in non-melanoma skin cancer. Part II: review and update on epidemiologic correlations. Skinmed 3:132-139.
7. Anwar J, Wrone DA, Kimyai-Asadi A, Alam M. 2004. The development of actinic keratosis into invasive squamous cell carcinoma: evidence and evolving classification schemes. Clin Dermatol 22:189-196.
8. Ashton KJ, Weinstein SR, Maguire DJ, Griffiths LR. 2001. Molecular cytogenetic analysis of basal cell carcinoma DNA using comparative genomic hybridization. J Invest Dermatol 117:683-686.
9. Ashton KJ, Weinstein SR, Maguire DJ, Griffiths LR. 2003. Chromosomal aberrations in squamous cell carcinoma and solar keratoses revealed by comparative genomic hybridization. Arch Dermatol 139:876-882.
10. Atkin NB, Baker MC. 1995. Ectopic nucleolar organizer regions. A common anomaly revealed by Ag-NOR staining of metaphases from nine cancers. Cancer Genet Cytogenet 85:129-132.
11. Bell HK, Rhodes LE. 1999. Bowen's disease-a retrospective review of clinical management. Clin Exp Dermatol 24:338-339.
12. Biesterfeld S, Pennings K, Grussendorf-Conen EI, Booking A. 1995. Aneuploidy in actinic keratosis and Bowen's disease-increased risk for invasive squamous cell carcinoma? Br J Dermatol 133:557-560.
13. Bignold LP. 2004. Carcinogen-induced impairment of enzymes for replicative fidelity of DNA and the initiation of tumours. Carcinogenesis 25:299-307.
14. Boukamp P, Popp S, Altmeyer S, Hulsen A, Fasching C, Cremer T, Fusenig NE. 1997. Sustained nontumorigenic phenotype correlates with a largely stable chromosome content during long-term culture of the human keratinocyte line HaCaT. Genes Chromosomes Cancer 19:201-214.
15. Bradley MO. 1981. Double-strand breaks in DNA caused by repair of damage due to ultraviolet light. J Supramol Struct Cell Biochem 16:337-343.
16. Brash DE. 1997. Sunlight and the onset of skin cancer. Trends Genet 13:410-414.
17. Broekmans WM, Vink AA, Boelsma E, Klopping-Ketelaars WA, Tijburg LB, van't Veer P, van Poppel G, Kardinaal AF. 2003. Determinants of skin sensitivity to solar irradiation. Eur J Clin Nutr 57:1222-1229.
18. Bykov VJ, Marcusson JA, Hemminki K. 2000. Effect of constitutional pigmentation on ultraviolet B-induced DNA damage in fair-skinned people. J Invest Dermatol 114:40-43.
19. Cai WW, Mao JH, Chow CW, Damani S, Balmain A, Bradley A. 2002. Genome-wide detection of chromosomal imbalances in tumors using BAG microarrays. Nat Biotechnol 20:393-396.
20. Cardoso J, Molenaar L, de Menezes RX, Rosenberg C, Morreau H, Moslein G, Fodde R, Boer JM. 2004. Genomic profiling by DNA amplification of laser capture microdissected tissues and array CGH. Nucleic Acids Res 32:e146.
21. Casalone R, Mazzola D, Righi R, Granata P, Minelli E, Salvadore M, Lombardo M, Bertani E. 2000. Cytogenetic and interphase FISH analyses of 73 basal cell and three squamous cell carcinomas: different findings in direct preparations and short-term cell cultures. Cancer Genet Cytogenet 118:136-143.
22. Chang TG, Wang J, Chen LW, Hsu CY, Chang HW, Chen JS, Cho CL. 1997. Loss of expression of the p16 gene is frequent in malignant skin tumors. Biochem Biophys Res Commun 230:85-88.
23. Chen Z, Sandberg AA. 2002. Molecular cytogenetic aspects of hematological malignancies: clinical implications. Am J Med Genet 115:130-141.
24. Cheville JC, Bromley C, Argenyi ZB. 1995. Trisomy 7 in keratoacanthoma and squamous cell carcinoma detected by fluorescence in-situ hybridization. J Cutan Pathol 22:546-550.
25. Clausen OP, Beigi M, Bolund L, Kolvraa S, Gjersvik PJ, Mork G, de Angelis PM. 2002. Keratoacanthomas frequently show chromosomal aberrations as assessed by comparative genomic hybridization. J Invest Dermatol 119:1367-1372.
26. De Preter K, Vandesompele J, Heimann P, Kockx MM, Van Gele M, Hoebeeck J, De Smet E, Demarche M, Laureys G, Van Roy N, De Paepe A, Speleman F 2003. Application of laser capture microdissection in genetic analysis of neuroblastoma and neuroblastoma precursor cells. Cancer Lett 197:53-61.
27. Diepgen TL, Mahler V. 2002. The epidemiology of skin cancer. Br J Dermatol 61:1-6.
28. Döbler M, Schuh J, Kiesewetter F, Schell H, Liehr T, Gebhart E. 1999. Deletion monitoring in skin tumors by interphase-FISH using band-specific DNA probes. Int J Oncol 14:571-576.
29. Ehrhart JC, Gosselet FP, Culerrier RM, Sarasin A. 2003. UVB-induced mutations in human key gatekeeper genes governing signalling pathways and consequences for skin tumourigenesis. Photochem Photobiol Sci 2:825-834.
30. Emmert-Buck MR, Bonner RF, Smith PD, Chuaqui RF, Zhuang Z, Goldstein SR, Weiss RA, Liotta LA. 1996. Laser capture microdissection. Science 274:998-1001.
31. Emri G, Wenczl E, Van Erp P, Jans J, Roza L, Horkay I, Schothorst AA. 2000. Low doses of UVB or UVA induce chromosomal aberrations in cultured human skin cells. J Invest Dermatol 115:435-440.
32. Fortier-Beaulieu M, Laquerriere A, Thomine E, Lauret P, Hemet J. 1994. DNA flow-cytometric analysis of basal cell carcinomas and its relevance to their morphological differentiation: a retrospective study. Dermatology 188:94-99.
33. Frentz G, Moller U. 1983. DNA flow cytometry of human epidermis: interindividual and regional variations in normal skin. Clin Exp Dermatol 8:19-26.
34. Green CL, Khavari PA. 2004. Targets for molecular therapy of skin cancer. Semin Cancer Biol 14:63-69.
35. Hahn H, Wicking C, Zaphiropoulous PG, Gailani MR, Shanley S, Chidambaram A, Vorechovsky I, Holmberg E, Linden AB, Gillies S, Negus K, Smyth I, Pressman C, Leffell DJ, Gerrard B, Goldstein AM, Dean M, Toftgard R, Chenevix-Trench G, Wainwright B, Bale AE. 1996. Mutations of the human homolog of Drosophila patched in the nevoid basal cell carcinoma syndrome. Cell 85:841-851.
36. Happle R. 1999. Loss of heterozygosity in human skin. J Am Acad Dermatol 41:143-164.
37. Herzberg AJ, Kerns BJ, Pollack SV, Kinney RB. 1991. DNA image cytometry of keratoacanthoma and squamous cell carcinoma. J Invest Dermatol 97:495-500.
38. Housman TS, Feldman SR, Williford PM, Fleischer AB Jr, Goldman ND, Acostamadiedo JM, Chen GJ. 2003. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol 48:425-429.
39. Imreh S, Klein G, Zabarovsky ER. 2003. Search for unknown tumor-antagonizing genes. Genes Chromosomes Cancer 38:307-321.
40. James L, Varley J. 1996. Advances in cytogenetic analysis of solid tumors. Chromosome Res 4:479-485.
41. James LA. 1999. Comparative genomic hybridization as a tool in tumour cytogenetics. J Pathol 187:385-395.
42. Jin Y, Mertens F, Persson B, Warloe T, Gullestad HP, Salemark L, Jin C, Jonsson N, Risberg B, Mandahl N, Mitelman F, Heim S. 1998. Nonrandom numerical chromosome abnormalities in basal cell carcinomas. Cancer Genet Cytogenet 103:35-42.
43. Jin Y, Martins C, Jin C, Salemark L, Jonsson N, Persson B, Roque L, Fonseca I, Wennerberg J. 1999. Nonrandom karyotypic features in squamous cell carcinomas of the skin. Genes Chromosomes Cancer 26:295-303.
44. Jin Y, Martins C, Salemark L, Persson B, Jin C, Miranda J, Fonseca I, Jonsson N. 2001. Nonrandom karyotypic features in basal cell carcinomas of the skin. Cancer Genet Cytogenet 131:109-119.
45. Jin Y, Jin C, Salemark L, Wennerberg J, Persson B, Jonsson N. 2002. Clonal chromosome abnormalities in premalignant lesions of the skin. Cancer Genet Cytogenet 136:48-52.
46. Johnson RL, Rothman AL, Xie J, Goodrich LV, Bare JW, Bonifas JM, Quinn AG, Myers RM, Cox DR, Epstein EH Jr, Scott MP. 1996. Human homolog of patched, a candidate gene for the basal cell nevus syndrome. Science 272:1668-1671.
47. Kane CL, Keehn CA, Smithberger E, Glass LF. 2004. Histopathology of cutaneous squamous cell carcinoma and its variants. Semin Cutan Med Surg 23:54-61.
48. Kawara S, Takata M, Takehara K. 1999. High frequency of DNA aneuploidy detected by DNA flow cytometry in Bowen's disease. J Dermatol Sci 21:23-26.
49. Kim DK, Kim JY, Kim HT, Han KH, Shon DG. 2003. A specific chromosome aberration in a keratoacanthoma. Cancer Genet Cytogenet 142:70-72.
50. Knudson AG Jr. 1971. Mutation and cancer: statistical study of retinoblastoma. Proc Natl Acad Sci USA 68:820-823.
51. Knuutila S. 2004. Cytogenetics and molecular pathology in cancer diagnostics. Ann Med 36:162-171.
52. Korabiowska M, Berger H, Keci A, Nagel H, Ruschenburg I, Droese M, Brinck U. 1999. Comparison of the DNA content in the different steps of cutaneous carcinoma progression. In Vivo 13:553-557.
53. Koyama N, Nishihira J, Nakabayashi H, Nishi S, Hoshi N, Fujimoto S, Shimizu M, Yoshiki T, Sugihara T. 2000. Aneuploidy of sex chromosomes in basal cell carcinoma: its clonality and involvement in the development of carcinogenesis. Int J Oncol 16:15-23.
54. Kraemer KH. 1997. Sunlight and skin cancer: another link revealed. Proc Natl Acad Sci USA 94:11-14.
55. Kubo Y, Urano Y, Matsumoto K, Ahsan K, Arase S. 1997. Mutations of the INK4a locus in squamous cell carcinomas of human skin. Biochem Biophys Res Commun 232:38-41.
56. Lee HJ, Kim JS, Ha SJ, Roh KY, Seo EJ, Park WS, Lee JY, Park KS, Kim JW. 2000. p53 Gene mutations in Bowen's disease in Koreans: clustering in exon 5 and multiple mutations. Cancer Lett 158:27-33.
57. Lengauer C, Kinzler KW, Vogelstein B. 1998. Genetic instabilities in human cancers. Nature 396:643-649.
58. Mantripragada KK, Buckley PG, de Stahl TD, Dumanski JP. 2004. Genomic microarrays in the spotlight. Trends Genet 20:87-94.
59. Matsumura Y, Ananthaswamy HN. 2004. Toxic effects of ultraviolet radiation on the skin. Toxicol Appl Pharmacol 195:298-308.
60. Melisi D, Troiani T, Damiano V, Tortora G, Ciardiello F. 2004. Therapeutic integration of signal transduction targeting agents and conventional anti-cancer treatments. Endocr Relat Cancer 11:51-68.
61. Mertens F, Heim S, Mandahl N, Johansson B, Rydholm A, Biorklund A, Wennerberg J, Jonsson N, Mitelman F. 1989. Clonal chromosome aberrations in a keratoacanthoma and a basal cell papilloma. Cancer Genet Cytogenet 39:227-232.
62. Mertens F, Heim S, Mandahl N, Johansson B, Mertens O, Persson K, Salemark L, Wennerberg J, Jonsson N, Mitelman F. 1991. Cytogenetic analysis of 33 basal cell carcinomas. Cancer Res 51:954-957.
63. Mitelman F, Johansson B, Mertens F. 2004. Mitelman Database of Chromosome Aberrations in Cancer. Available at: http://cgap.nci.nih.gov/Chromosomes/ Mitelman
64. Mortier L, Marchetti P, Delaporte E, Martin de Lassalle E, Thomas P, Piette F, Formstecher P, Polakowska R, Danze PM. 2002. Progression of actinic keratosis to squamous cell carcinoma of the skin correlates with deletion of the 9p21 region encoding the p16(INK4a) tumor suppressor. Cancer Lett 176:205-214.
65. Mühlmann M. 2002. Molecular cytogenetics in metaphase and interphase cells for cancer and genetic research, diagnosis and prognosis. Application in tissue sections and cell suspensions. Genet Mol Res 1:117-127.
66. Nguyen TH. 2004. Mechanisms of metastasis. Clin Dermatol 22:209-216.
67. Oostlander A, Meijer G, Ylstra B. 2004. Microarray-based comparative genomic hybridization and its applications in human genetics. Clin Genet 66:488-495.
68. Ortonne JP. 2002. From actinic keratosis to squamous cell carcinoma. Br J Dermatol s61:20-23.
69. Pavarino EC, Rossit AR, Tajara EH. 1997. Chromosome breakpoint distribution in nonmelanoma skin cancers. Cancer Genet Cytogenet 99:81-84.
70. Pilch H, Weiss J, Heubner C, Heine M. 1994. Differential diagnosis of keratoacanthomas and squamous cell carcinomas: diagnostic value of DNA image cytometry and p53 expression. J Cutan Pathol 21:507-513.
71. Popp S, Waltering S, Holtgreve-Grez H, Jauch A, Proby C, Leigh IM, Boukamp P. 2000. Genetic characterization of a human skin carcinoma progression model: from primary tumor to metastasis. J Invest Dermatol 115:1095-1103.
72. Quinn AG. 1997. Ultraviolet radiation and skin carcinogenesis. Br J Hosp Med 58:261-264.
73. Quinn AG, Sikkink S, Rees JL. 1994. Basal cell carcinomas and squamous cell carcinomas of human skin show distinct patterns of chromosome loss. Cancer Res 54:4756-4759.
74. Rehman I, Quinn AG, Healy E, Rees JL. 1994. High frequency of loss of heterozygosity in actinic keratoses, a usually benign disease. Lancet 344:788-789.
75. Rehman I, Takata M, Wu YY, Rees JL. 1996. Genetic change in actinic keratoses. Oncogene 12:2483-2490.
76. Robinson JK, Rademaker AW, Goolsby C, Traczyk TN, Zoladz C. 1996. DNA ploidy in nonmelanoma skin cancer. Cancer 77:284-291.
77. Saldanha G, Fletcher A, Slater DN. 2003. Basal cell carcinoma: a dermatopathological and molecular biological update. Br J Dermatol 148:195-202.
78. Sarasin A. 1999. The molecular pathways of utraviolet-induced carcinogenesis. Mutat Res 428:5-10.
79. Saridaki Z, Koumantaki E, Liloglou T, Sourvinos G, Papadopoulos O, Zoras O, Spandidos DA. 2000. High frequency of loss of heterozygosity on chromosome region 9p21-p22 but lack of p16INK4a/p19ARF mutations in Greek patients with basal cell carcinoma of the skin. J Invest Dermatol 115:719-725.
80. Saridaki Z, Liloglou T, Zafiropoulos A, Koumantaki E, Zoras O, Spandidos DA. 2003. Mutational analysis of CDKN2A genes in patients with squamous cell carcinoma of the skin. Br J Dermatol 148:638-648.
81. Scappaticci FA, Marina N. 2001. New molecular targets and biological therapies in sarcomas. Cancer Treat Rev 27:317-326.
82. Schaeffer AJ, Nguyen M, Liem A, Lee D, Montagna C, Lambert PF, Ried T, Difilippantonio MJ. 2004. E6 and E7 oncoproteins induce distinct patterns of chromosomal aneuploidy in skin tumors from transgenic mice. Cancer Res 64:538-546.
83. Schwartz RA. 2004. Keratoacanthoma: a clinico-pathologic enigma. Dermatol Surg 30:326-333.
84. Shanley SM, Dawkins H, Wainwright BJ, Wicking C, Heenan P, Eldon M, Searle J, Chenevix-Trench G. 1995. Fine deletion mapping on the long arm of chromosome 9 in sporadic and familial basal cell carcinomas. Hum Mol Genet 4:129-133.
85. Shen T, Park WS, Boni R, Saini N, Pham T, Lash AE, Vortmeyer AO, Zhuang Z. 1999. Detection of loss of heterozygosity on chromosome 9q22.3 in microdissected sporadic basal cell carcinoma. Hum Pathol 30:284-287.
86. Shimizu T, Izumi H, Oga A, Furumoto H, Murakami T, Ofuji R, Muto M, Sasaki K. 2001. Epidermal growth factor receptor overexpression and genetic aberrations in metastatic squamous-cell carcinoma of the skin. Dermatology 202:203-206.
87. Sikkink SK, Rehman I, Rees JL. 1997. Deletion mapping of chromosome 3p and 13q and preliminary analysis of the FHIT gene in human nonmelanoma skin cancer. J Invest Dermatol 109:801-805.
88. Soufir N, Moles JP, Vilmer C, Moch C, Verola O, Rivet J, Tesniere A, Dubertret L, Basset-Seguin N. 1999. P16 UV mutations in human skin epithelial tumors. Oncogene 18:5477-5481.
89. Speight EL, Dahl MG, Farr PM. 1994. Actinic keratosis induced by use of sunbed. BMJ 308:415.
90. Staibano S, Lo Muzio L, Pannone G, Mezza E, Argenziano G, Vetrani A, Lucariello A, Franco R, Errico ME, De Rosa G. 2001. DNA ploidy and cyclin D1 expression in basal cell carcinoma of the head and neck. Am J Clin Pathol 115:805-813.
91. Tanimoto K, Hayashi S, Tsuchiya E, Tokuchi Y, Kobayashi Y, Yoshiga K, Okui T, Kobayashi M, Ichikawa T. 2000. Abnormalities of the FHIT gene in human oral carcinogenesis. Br J Cancer 82:838-843.
92. Thompson CT, Gray JW. 1993. Cytogenetic profiling using fluorescence in situ hybridization (FISH) and comparative genomic hybridization (CGH). J Cell Biochem Suppl 17G:139-143.
93. Tsai KY, Tsao H. 2004. The genetics of skin cancer. Am J Med Genet 131C:82-92.
94. Tsao H. 2001. Genetics of nonmelanoma skin cancer. Arch Dermatol 137:1486-1492.
95. Varella-Garcia M. 2003. Molecular cytogenetics in solid tumors: laboratorial tool for diagnosis, prognosis, and therapy. Oncologist 8:45-58.
96. Vogelstein B, Kinzler KW. 2004. Cancer genes and the pathways they control. Nat Med 10:789-799.
97. Waring AJ, Takata M, Rehman I, Rees JL. 1996. Loss of heterozygosity analysis of keratoacanthoma reveals multiple differences from cutaneous squamous cell carcinoma. Br J Cancer 73:649-653.
98. Wicking C, McGlinn E. 2001. The role of hedgehog signalling in tumorigenesis. Cancer Lett 173:1-7.
99. Worsham MJ, Carey TE, Benninger MS, Gasser KM, Kelker W, Zarbo RJ, Van Dyke DL. 1993. Clonal cytogenetic evolution in a squamous cell carcinoma of the skin from a xeroderma pigmentosum patient. Genes Chromosomes Cancer 7:158-164.